Global Cancer Monoclonal Antibodies Market Research Report 2017

December 2017 | 112 pages | ID: G9F4C872274EN
QYResearch

Abstracts

In this report, the global Cancer Monoclonal Antibodies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cancer Monoclonal Antibodies in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Cancer Monoclonal Antibodies market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• F. Hoffmann-La Roche
• Amgen
• Bristol-Myers Squibb
• Takeda Pharmaceuticals
• Pfizer
• Merck
• Eli Lilly
• Sanofi
• Janssen Biotech
• Novartis
• AbbVie
• Boehringer Ingelheim
• AstraZeneca
• Bayer
• Biogen
• TG Therapeutics
• CTI BioPharma
• Intas Pharmaceuticals
• Kyowa Hakko Kirin

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Naked mAbs
• Conjugated mAbs

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Hospitals
• Retail Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Cancer Monoclonal Antibodies Market Research Report 2017

1 CANCER MONOCLONAL ANTIBODIES MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Monoclonal Antibodies
1.2 Cancer Monoclonal Antibodies Segment by Type (Product Category)
  1.2.1 Global Cancer Monoclonal Antibodies Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Cancer Monoclonal Antibodies Production Market Share by Type (Product Category) in 2016
  1.2.3 Naked mAbs
  1.2.4 Conjugated mAbs
1.3 Global Cancer Monoclonal Antibodies Segment by Application
  1.3.1 Cancer Monoclonal Antibodies Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Retail Pharmacies
1.4 Global Cancer Monoclonal Antibodies Market by Region (2012-2022)
  1.4.1 Global Cancer Monoclonal Antibodies Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Cancer Monoclonal Antibodies (2012-2022)
  1.5.1 Global Cancer Monoclonal Antibodies Revenue Status and Outlook (2012-2022)
  1.5.2 Global Cancer Monoclonal Antibodies Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET COMPETITION BY MANUFACTURERS

2.1 Global Cancer Monoclonal Antibodies Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Cancer Monoclonal Antibodies Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Cancer Monoclonal Antibodies Production and Share by Manufacturers (2012-2017)
2.2 Global Cancer Monoclonal Antibodies Revenue and Share by Manufacturers (2012-2017)
2.3 Global Cancer Monoclonal Antibodies Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Cancer Monoclonal Antibodies Manufacturing Base Distribution, Sales Area and Product Type
2.5 Cancer Monoclonal Antibodies Market Competitive Situation and Trends
  2.5.1 Cancer Monoclonal Antibodies Market Concentration Rate
  2.5.2 Cancer Monoclonal Antibodies Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL CANCER MONOCLONAL ANTIBODIES CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Cancer Monoclonal Antibodies Capacity and Market Share by Region (2012-2017)
3.2 Global Cancer Monoclonal Antibodies Production and Market Share by Region (2012-2017)
3.3 Global Cancer Monoclonal Antibodies Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL CANCER MONOCLONAL ANTIBODIES SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Cancer Monoclonal Antibodies Consumption by Region (2012-2017)
4.2 North America Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)
4.3 Europe Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)
4.4 China Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)
4.5 Japan Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)
4.7 India Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)

5 GLOBAL CANCER MONOCLONAL ANTIBODIES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Cancer Monoclonal Antibodies Production and Market Share by Type (2012-2017)
5.2 Global Cancer Monoclonal Antibodies Revenue and Market Share by Type (2012-2017)
5.3 Global Cancer Monoclonal Antibodies Price by Type (2012-2017)
5.4 Global Cancer Monoclonal Antibodies Production Growth by Type (2012-2017)

6 GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET ANALYSIS BY APPLICATION

6.1 Global Cancer Monoclonal Antibodies Consumption and Market Share by Application (2012-2017)
6.2 Global Cancer Monoclonal Antibodies Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL CANCER MONOCLONAL ANTIBODIES MANUFACTURERS PROFILES/ANALYSIS

7.1 F. Hoffmann-La Roche
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Amgen
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Amgen Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Bristol-Myers Squibb
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Bristol-Myers Squibb Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Takeda Pharmaceuticals
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Pfizer Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Merck
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Merck Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Eli Lilly
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Eli Lilly Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Sanofi
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Sanofi Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Janssen Biotech
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Janssen Biotech Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Novartis
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Novartis Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 AbbVie
7.12 Boehringer Ingelheim
7.13 AstraZeneca
7.14 Bayer
7.15 Biogen
7.16 TG Therapeutics
7.17 CTI BioPharma
7.18 Intas Pharmaceuticals
7.19 Kyowa Hakko Kirin

8 CANCER MONOCLONAL ANTIBODIES MANUFACTURING COST ANALYSIS

8.1 Cancer Monoclonal Antibodies Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Monoclonal Antibodies

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Cancer Monoclonal Antibodies Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Monoclonal Antibodies Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET FORECAST (2017-2022)

12.1 Global Cancer Monoclonal Antibodies Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Cancer Monoclonal Antibodies Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Cancer Monoclonal Antibodies Price and Trend Forecast (2017-2022)
12.2 Global Cancer Monoclonal Antibodies Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Cancer Monoclonal Antibodies Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Cancer Monoclonal Antibodies Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Monoclonal Antibodies
Figure Global Cancer Monoclonal Antibodies Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Cancer Monoclonal Antibodies Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Naked mAbs
Table Major Manufacturers of Naked mAbs
Figure Product Picture of Conjugated mAbs
Table Major Manufacturers of Conjugated mAbs
Figure Global Cancer Monoclonal Antibodies Consumption (K Units) by Applications (2012-2022)
Figure Global Cancer Monoclonal Antibodies Consumption Market Share by Applications in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Global Cancer Monoclonal Antibodies Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Cancer Monoclonal Antibodies Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Cancer Monoclonal Antibodies Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Cancer Monoclonal Antibodies Major Players Product Capacity (K Units) (2012-2017)
Table Global Cancer Monoclonal Antibodies Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Cancer Monoclonal Antibodies Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Cancer Monoclonal Antibodies Capacity (K Units) of Key Manufacturers in 2016
Figure Global Cancer Monoclonal Antibodies Capacity (K Units) of Key Manufacturers in 2017
Figure Global Cancer Monoclonal Antibodies Major Players Product Production (K Units) (2012-2017)
Table Global Cancer Monoclonal Antibodies Production (K Units) of Key Manufacturers (2012-2017)
Table Global Cancer Monoclonal Antibodies Production Share by Manufacturers (2012-2017)
Figure 2016 Cancer Monoclonal Antibodies Production Share by Manufacturers
Figure 2017 Cancer Monoclonal Antibodies Production Share by Manufacturers
Figure Global Cancer Monoclonal Antibodies Major Players Product Revenue (Million USD) (2012-2017)
Table Global Cancer Monoclonal Antibodies Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Cancer Monoclonal Antibodies Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Cancer Monoclonal Antibodies Revenue Share by Manufacturers
Table 2017 Global Cancer Monoclonal Antibodies Revenue Share by Manufacturers
Table Global Market Cancer Monoclonal Antibodies Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Cancer Monoclonal Antibodies Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Cancer Monoclonal Antibodies Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Monoclonal Antibodies Product Category
Figure Cancer Monoclonal Antibodies Market Share of Top 3 Manufacturers
Figure Cancer Monoclonal Antibodies Market Share of Top 5 Manufacturers
Table Global Cancer Monoclonal Antibodies Capacity (K Units) by Region (2012-2017)
Figure Global Cancer Monoclonal Antibodies Capacity Market Share by Region (2012-2017)
Figure Global Cancer Monoclonal Antibodies Capacity Market Share by Region (2012-2017)
Figure 2016 Global Cancer Monoclonal Antibodies Capacity Market Share by Region
Table Global Cancer Monoclonal Antibodies Production by Region (2012-2017)
Figure Global Cancer Monoclonal Antibodies Production (K Units) by Region (2012-2017)
Figure Global Cancer Monoclonal Antibodies Production Market Share by Region (2012-2017)
Figure 2016 Global Cancer Monoclonal Antibodies Production Market Share by Region
Table Global Cancer Monoclonal Antibodies Revenue (Million USD) by Region (2012-2017)
Table Global Cancer Monoclonal Antibodies Revenue Market Share by Region (2012-2017)
Figure Global Cancer Monoclonal Antibodies Revenue Market Share by Region (2012-2017)
Table 2016 Global Cancer Monoclonal Antibodies Revenue Market Share by Region
Figure Global Cancer Monoclonal Antibodies Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Cancer Monoclonal Antibodies Consumption (K Units) Market by Region (2012-2017)
Table Global Cancer Monoclonal Antibodies Consumption Market Share by Region (2012-2017)
Figure Global Cancer Monoclonal Antibodies Consumption Market Share by Region (2012-2017)
Figure 2016 Global Cancer Monoclonal Antibodies Consumption (K Units) Market Share by Region
Table North America Cancer Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Cancer Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Cancer Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Cancer Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Cancer Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Cancer Monoclonal Antibodies Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Cancer Monoclonal Antibodies Production (K Units) by Type (2012-2017)
Table Global Cancer Monoclonal Antibodies Production Share by Type (2012-2017)
Figure Production Market Share of Cancer Monoclonal Antibodies by Type (2012-2017)
Figure 2016 Production Market Share of Cancer Monoclonal Antibodies by Type
Table Global Cancer Monoclonal Antibodies Revenue (Million USD) by Type (2012-2017)
Table Global Cancer Monoclonal Antibodies Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Cancer Monoclonal Antibodies by Type (2012-2017)
Figure 2016 Revenue Market Share of Cancer Monoclonal Antibodies by Type
Table Global Cancer Monoclonal Antibodies Price (USD/Unit) by Type (2012-2017)
Figure Global Cancer Monoclonal Antibodies Production Growth by Type (2012-2017)
Table Global Cancer Monoclonal Antibodies Consumption (K Units) by Application (2012-2017)
Table Global Cancer Monoclonal Antibodies Consumption Market Share by Application (2012-2017)
Figure Global Cancer Monoclonal Antibodies Consumption Market Share by Applications (2012-2017)
Figure Global Cancer Monoclonal Antibodies Consumption Market Share by Application in 2016
Table Global Cancer Monoclonal Antibodies Consumption Growth Rate by Application (2012-2017)
Figure Global Cancer Monoclonal Antibodies Consumption Growth Rate by Application (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Cancer Monoclonal Antibodies Production Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Cancer Monoclonal Antibodies Production Market Share (2012-2017)
Figure F. Hoffmann-La Roche Cancer Monoclonal Antibodies Revenue Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Cancer Monoclonal Antibodies Production Growth Rate (2012-2017)
Figure Amgen Cancer Monoclonal Antibodies Production Market Share (2012-2017)
Figure Amgen Cancer Monoclonal Antibodies Revenue Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Cancer Monoclonal Antibodies Production Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Cancer Monoclonal Antibodies Production Market Share (2012-2017)
Figure Bristol-Myers Squibb Cancer Monoclonal Antibodies Revenue Market Share (2012-2017)
Table Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceuticals Cancer Monoclonal Antibodies Production Growth Rate (2012-2017)
Figure Takeda Pharmaceuticals Cancer Monoclonal Antibodies Production Market Share (2012-2017)
Figure Takeda Pharmaceuticals Cancer Monoclonal Antibodies Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Cancer Monoclonal Antibodies Production Growth Rate (2012-2017)
Figure Pfizer Cancer Monoclonal Antibodies Production Market Share (2012-2017)
Figure Pfizer Cancer Monoclonal Antibodies Revenue Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Cancer Monoclonal Antibodies Production Growth Rate (2012-2017)
Figure Merck Cancer Monoclonal Antibodies Production Market Share (2012-2017)
Figure Merck Cancer Monoclonal Antibodies Revenue Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Cancer Monoclonal Antibodies Production Growth Rate (2012-2017)
Figure Eli Lilly Cancer Monoclonal Antibodies Production Market Share (2012-2017)
Figure Eli Lilly Cancer Monoclonal Antibodies Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Cancer Monoclonal Antibodies Production Growth Rate (2012-2017)
Figure Sanofi Cancer Monoclonal Antibodies Production Market Share (2012-2017)
Figure Sanofi Cancer Monoclonal Antibodies Revenue Market Share (2012-2017)
Table Janssen Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Biotech Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Biotech Cancer Monoclonal Antibodies Production Growth Rate (2012-2017)
Figure Janssen Biotech Cancer Monoclonal Antibodies Production Market Share (2012-2017)
Figure Janssen Biotech Cancer Monoclonal Antibodies Revenue Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Cancer Monoclonal Antibodies Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Cancer Monoclonal Antibodies Production Growth Rate (2012-2017)
Figure Novartis Cancer Monoclonal Antibodies Production Market Share (2012-2017)
Figure Novartis Cancer Monoclonal Antibodies Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Monoclonal Antibodies
Figure Manufacturing Process Analysis of Cancer Monoclonal Antibodies
Figure Cancer Monoclonal Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Cancer Monoclonal Antibodies Major Manufacturers in 2016
Table Major Buyers of Cancer Monoclonal Antibodies
Table Distributors/Traders List
Figure Global Cancer Monoclonal Antibodies Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Monoclonal Antibodies Price (Million USD) and Trend Forecast (2017-2022)
Table Global Cancer Monoclonal Antibodies Production (K Units) Forecast by Region (2017-2022)
Figure Global Cancer Monoclonal Antibodies Production Market Share Forecast by Region (2017-2022)
Table Global Cancer Monoclonal Antibodies Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Cancer Monoclonal Antibodies Consumption Market Share Forecast by Region (2017-2022)
Figure North America Cancer Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Cancer Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Cancer Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Cancer Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Cancer Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Cancer Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Cancer Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Cancer Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Cancer Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Cancer Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Cancer Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Cancer Monoclonal Antibodies Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Cancer Monoclonal Antibodies Production (K Units) Forecast by Type (2017-2022)
Figure Global Cancer Monoclonal Antibodies Production (K Units) Forecast by Type (2017-2022)
Table Global Cancer Monoclonal Antibodies Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Cancer Monoclonal Antibodies Revenue Market Share Forecast by Type (2017-2022)
Table Global Cancer Monoclonal Antibodies Price Forecast by Type (2017-2022)
Table Global Cancer Monoclonal Antibodies Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Cancer Monoclonal Antibodies Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source